drugset / Trial / NCT05786950
Neural Respiratory Drive of Patients With Chronic Obstructive Pulmonary Disease
NaSingle-groupOpen-labelBasic science
Summary
To investigate the relationship among the neural respiratory drive (NRD), the sensation of the dyspnea and the effect of the bronchodilator on each stage COPD patients.
Timeline
- Start
- 2023-01-01
- Primary completion
- 2023-07-01
- Completion
- 2024-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ipratropium | Small molecule | 500 ug | Inhaled |
| Subject | Salbutamol | Unknown | 3 mg | Inhaled |